# Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment

> **NCT00220831** · PHASE2,PHASE3 · TERMINATED · sponsor: **Technion, Israel Institute of Technology** · enrollment: 2000 (—)

## Conditions studied

- Diabetes
- Myocardial Infarction
- Cardiovascular Disease

## Interventions

- **DRUG:** Natural source Vitamin E 400IU/day

## Key facts

- **NCT ID:** NCT00220831
- **Lead sponsor:** Technion, Israel Institute of Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** 2009-12
- **Target enrollment:** 2000 (—)
- **Why stopped:** interim analysis showed significant differences between two treatment groups
- **Last updated:** 2007-03-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00220831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00220831, "Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00220831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*